Faga Daniel bought TRAX

May 12, 2026 · Form 4 insider transaction

Faga Daniel bought 271,100 shares of First Tracks Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
271,100
Price
$0.00
Total value
N/A
RoleOfficer, Director
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMay 12, 2026
Filing dateMay 14, 2026
Shares owned after271,100
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The stock option vests as to 25% of the total shares on May 12, 2027, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.; In addition to the options to purchase a total of 271,100 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 1,035,941 shares of common stock, which options vest according to their terms.

View the original Form 4 on SEC EDGAR